Home LiteratureArticle Details
PMID: 8986812 Published · ppublish English Comparative Study Journal Article

Identification of a novel p53 functional domain that is necessary for efficient growth suppression.

Walker KK, Levine AJ

Abstract

Activation of the p53 tumor suppressor protein has been demonstrated to block cell growth by inducing either a transient cell cycle arrest or programmed cell death (apoptosis). Although evidence exists linking p53's function as an activator of transcription to its ability to effect cell cycle arrest, the role of this activity in the induction of apoptosis remains unclear. To gain insight into the molecular mechanisms underlying p53-mediated antiproliferative pathways, a study was initiated to explore the functions of a putative p53 signaling domain. This region of the human p53 protein is localized between amino acids 61 and 94 (out of 393) and is noteworthy in that it contains five repeats of the sequence PXXP (where P represents proline and X any amino acid). This motif has been shown to play a role in signal transduction via its SH3 domain binding activity. A p53 cDNA deletion mutant (delta pro AE), which lacks this entire proline-rich domain (deleted for amino acids 62-91), was created and characterized for a variety of p53 functions. The entire domain has been shown to be completely dispensable for transcriptional activation. On the other hand, this deletion of the p53 proline-rich domain impairs p53's ability to suppress tumor cell growth in culture. Amino acid substitution mutations at residues 22 and 23 of p53 (eliminates transcriptional activity) also impair p53-mediated inhibition of cell growth in culture. Unlike wild-type p53, the delta proAE mutant cDNA can be stably expressed in tumor derived cell lines with few immediate detrimental effects. These cells express physiologic levels of p53 protein that are induced normally in response to DNA damage, indicating that removal of the proline-rich domain does not disrupt p53's upstream regulation by DNA damage. These data indicate that, in addition to the transcriptional activation domain, the p53 proline-rich domain plays a critical role in the transmission of antiproliferative signals down-stream of the p53 protein and may link p53 to a direct signal transduction pathway.

MeSH Terms
Amino Acid Sequence Animals Apoptosis Carcinoma, Non-Small-Cell Lung Cell Cycle Cell Division Cell Line Chickens DNA Damage Genes, p53 Haplorhini Humans Lung Neoplasms Mice Molecular Sequence Data Mutagenesis, Site-Directed Proline Rats Recombinant Proteins/chemistry,metabolism Sequence Deletion Sequence Homology, Amino Acid Transcriptional Activation Transfection Tumor Suppressor Protein p53/biosynthesis,chemistry,physiology
Chemicals
Recombinant Proteins Tumor Suppressor Protein p53 Proline
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Walker K K
Department of Molecular Biology, Prineton University, NJ 08544, USA.
Levine A J
References (47)
47 references, click to expand
  1. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features.
    Oncogene. 1992 Jan;7(1):171-80 PMID: 1311061
  2. Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
    Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7491-5 PMID: 1323840
  3. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.
    Cell. 1992 Nov 13;71(4):587-97 PMID: 1423616
  4. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.
    Cell. 1992 Jun 26;69(7):1237-45 PMID: 1535557
  5. A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs.
    Proc Natl Acad Sci U S A. 1992 May 1;89(9):3952-6 PMID: 1570319
  6. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts.
    Genes Dev. 1991 Dec;5(12B):2375-85 PMID: 1752433
  7. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6.
    Nature. 1991 Jul 25;352(6333):345-7 PMID: 1852210
  8. p53 mutations in human cancers.
    Science. 1991 Jul 5;253(5015):49-53 PMID: 1905840
  9. Participation of p53 protein in the cellular response to DNA damage.
    Cancer Res. 1991 Dec 1;51(23 Pt 1):6304-11 PMID: 1933891
  10. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein.
    Genes Dev. 1991 Feb;5(2):151-9 PMID: 1995413
  11. Structural aspects of the p53 protein in relation to gene evolution.
    Oncogene. 1990 Jul;5(7):945-52 PMID: 2142762
  12. Presence of a potent transcription activating sequence in the p53 protein.
    Science. 1990 Aug 31;249(4972):1046-9 PMID: 2144363
  13. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene.
    Science. 1990 Aug 31;249(4972):1049-51 PMID: 2144364
  14. p53 functions as a cell cycle control protein in osteosarcomas.
    Mol Cell Biol. 1990 Nov;10(11):5772-81 PMID: 2233717
  15. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.
    Cell Growth Differ. 1990 Dec;1(12):571-80 PMID: 2288874
  16. A new technique for the assay of infectivity of human adenovirus 5 DNA.
    Virology. 1973 Apr;52(2):456-67 PMID: 4705382
  17. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells.
    Mol Cell Biol. 1984 Sep;4(9):1689-94 PMID: 6092932
  18. Structural basis for the binding of proline-rich peptides to SH3 domains.
    Cell. 1994 Mar 11;76(5):933-45 PMID: 7510218
  19. Protein modules and signalling networks.
    Nature. 1995 Feb 16;373(6515):573-80 PMID: 7531822
  20. Induction of apoptosis in HeLa cells by trans-activation-deficient p53.
    Genes Dev. 1995 Sep 1;9(17):2170-83 PMID: 7657168
  21. Human TAFII31 protein is a transcriptional coactivator of the p53 protein.
    Proc Natl Acad Sci U S A. 1995 May 23;92(11):5154-8 PMID: 7761466
  22. Identification of p53 target genes through immune selection of genomic DNA: the cyclin G gene contains two distinct p53 binding sites.
    Oncogene. 1995 Jun 15;10(12):2361-6 PMID: 7784084
  23. Refined solution structure of the oligomerization domain of the tumour suppressor p53.
    Nat Struct Biol. 1995 Apr;2(4):321-33 PMID: 7796267
  24. p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60.
    Science. 1995 Jan 6;267(5194):100-4 PMID: 7809597
  25. Modular binding domains in signal transduction proteins.
    Cell. 1995 Jan 27;80(2):237-48 PMID: 7834743
  26. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.
    Cell. 1995 Jan 27;80(2):293-9 PMID: 7834749
  27. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.
    Genes Dev. 1994 May 15;8(10):1235-46 PMID: 7926727
  28. Cyclin G is a transcriptional target of the p53 tumor suppressor protein.
    EMBO J. 1994 Oct 17;13(20):4816-22 PMID: 7957050
  29. Identification of Src, Fyn, Lyn, PI3K and Abl SH3 domain ligands using phage display libraries.
    EMBO J. 1994 Dec 1;13(23):5598-604 PMID: 7988556
  30. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.
    Genes Dev. 1994 Dec 1;8(23):2817-30 PMID: 7995520
  31. Transcriptional activation by p53 correlates with suppression of growth but not transformation.
    Cell. 1994 Dec 2;79(5):817-27 PMID: 8001119
  32. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.
    Science. 1994 Jul 15;265(5170):346-55 PMID: 8023157
  33. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes.
    Nature. 1994 Jul 21;370(6486):220-3 PMID: 8028670
  34. p53-dependent apoptosis suppresses tumor growth and progression in vivo.
    Cell. 1994 Aug 26;78(4):703-11 PMID: 8069917
  35. p53 and E2F-1 cooperate to mediate apoptosis.
    Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3602-6 PMID: 8170954
  36. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes?
    Cell. 1993 Nov 19;75(4):765-78 PMID: 8242748
  37. WAF1, a potential mediator of p53 tumor suppression.
    Cell. 1993 Nov 19;75(4):817-25 PMID: 8242752
  38. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.
    Genes Dev. 1993 Dec;7(12B):2565-74 PMID: 8276239
  39. The p53-mdm-2 autoregulatory feedback loop.
    Genes Dev. 1993 Jul;7(7A):1126-32 PMID: 8319905
  40. Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression.
    Mol Cell Biol. 1993 Sep;13(9):5186-94 PMID: 8355677
  41. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis.
    Genes Dev. 1993 Apr;7(4):535-45 PMID: 8384579
  42. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.
    Genes Dev. 1993 Apr;7(4):546-54 PMID: 8384580
  43. Production of human RAP30 and RAP74 in bacterial cells.
    Protein Expr Purif. 1993 Jun;4(3):207-14 PMID: 8390879
  44. p53 is required for radiation-induced apoptosis in mouse thymocytes.
    Nature. 1993 Apr 29;362(6423):847-9 PMID: 8479522
  45. Thymocyte apoptosis induced by p53-dependent and independent pathways.
    Nature. 1993 Apr 29;362(6423):849-52 PMID: 8479523
  46. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.
    Mol Med. 1995 Jan;1(2):142-52 PMID: 8529093
  47. p53: puzzle and paradigm.
    Genes Dev. 1996 May 1;10(9):1054-72 PMID: 8654922
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1996-12-24
Pages
15335-40
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC26405
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]